Immunomodulatory effects of mesenchymal stem cells in a murine model of TNBS-induced colitis

Journal of the Korean Surgical Society

Volumn 79, Issue 5, 2010, Pages 317-325

  Cho, Yong Beom ^a   Kim, Min Shik ^b   Kang, Min Jeong ^c   Shin, Hee Jung ^c   Kim, Seok Hyung ^a   Kim, Hee Cheol ^a   Yun, Seong Hyeon ^a   Lee, Woo Yong ^a   Chun, Ho Kyung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Samsung Medical Center   (South Korea)

Author keywords

Crohn's disease; Inflammatory bowel disease; Mesenchymal stem cell

Indexed keywords

EID: 79960155039     PISSN: 12260053     EISSN: 20930488     Source Type: Journal    
DOI: 10.4174/jkss.2010.79.5.317     Document Type: Article

References (31)

1. Podolsky DK. Inflammatory bowel disease (1). N Engl J Med 1991;325:928-37.
2. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205. (Pubitemid 28307304)
3. MacDonald TT, Monteleone G, Pender SL. Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol 2000;51:2-9. (Pubitemid 30074296)
4. Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 2001;120:622-35. (Pubitemid 32171636)
5. Geboes K. From inflammation to lesion. Acta Gastroenterol Belg 1994;57:273-84.
6. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-33. (Pubitemid 37328672)
7. Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003;3:331-41. (Pubitemid 37328685)
8. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007;117:514-21. (Pubitemid 46348505)
9. Sandborn WJ, Targan SR. Biologic therapy of inflammatory bowel disease. Gastroenterology 2002;122:1592-608. (Pubitemid 34533555)
10. Van Deventer SJ. Immunotherapy of Crohn's disease. Scand J Immunol 2000;51:18-22. (Pubitemid 30074298)
11. Le Blanc K, Ringdén O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 2007;262: 509-25. (Pubitemid 47620502)
12. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002;30:42-8. (Pubitemid 34059216)
13. Majumdar MK, Keane-Moore M, Buyaner D, Hardy WB, Moorman MA, McIntosh KR, et al. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 2003;10:228-41. (Pubitemid 36302404)
14. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105: 1815-22. (Pubitemid 40223708)
15. Frank MH, Sayegh MH. Immunomodulatory functions of mesenchymal stem cells. Lancet 2004;363:1411-2. (Pubitemid 38586712)
16. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-41. (Pubitemid 38586721)
17. Deng W, Han Q, Liao L, Li C, Ge W, Zhao Z, et al. Allogeneic bone marrow-derived flk-1+Sca-1-mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance. Exp Hematol 2004;32:861-7. (Pubitemid 39166033)
18. Ertel W, Keel M, Neidhardt R, Steckholzer U, Kremer JP, Ungethuem U, et al. Inhibition of the defense system stimulating interleukin-12 interferon-gamma pathway during critical illness. Blood 1997;89:1612-20. (Pubitemid 27097454)
19. Miner KT, Croft M. Generation, persistence, and modulation of Th0 effector cells: role of autocrine IL-4 and IFN-gamma. J Immunol 1998;160:5280-7. (Pubitemid 28267814)
20. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Köhler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993;362:245-8. (Pubitemid 23093629)
21. Chen L, Grabowski KA, Xin JP, Coleman J, Huang Z, Espiritu B, et al. IL-4 induces differentiation and expansion of Th2 cytokine-producing eosinophils. J Immunol 2004;172:2059-66. (Pubitemid 38182351)
22. Osugi Y, Hara J, Tagawa S, Takai K, Hosoi G, Matsuda Y, et al. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 1997;89:4100-3. (Pubitemid 27220957)
23. Rattigan Y, Hsu JM, Mishra PJ, Glod J, Banerjee D. Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu. Exp Cell Res. Epub 2010 Jul 13.
24. Stephens LA, Gray D, Anderton SM. CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. Proc Natl Acad Sci U S A 2005;102: 17418-23. (Pubitemid 41740881)
25. Baecher-Allan C, Viglietta V, Hafler DA. Human CD4+CD25+ regulatory T cells. Semin Immunol 2004;16:89-98.
26. Veltkamp C, Sartor RB, Giese T, Autschbach F, Kaden I, Veltkamp R, et al. Regulatory CD4+CD25+ cells reverse imbalances in the T cell pool of bone marrow transplanted TGepsilon26 mice leading to the prevention of colitis. Gut 2005;54:207-14. (Pubitemid 40139235)
27. Gärdby E, Chen XJ, Lycke NY. Impaired CD40-signalling in CD19-deficient mice selectively affects Th2-dependent isotype switching. Scand J Immunol 2001;53:13-23. (Pubitemid 32113352)
28. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006;8(Suppl 2):S3.
29. Lee J, Kim MS, Kim EY, Park HJ, Chang CY, Jung DY, et al. 15-deoxyspergualin prevents mucosal injury by inhibiting production of TNF-alpha and down-regulating expression of MD-1 in a murine model of TNBS-induced colitis. Int Immunopharmacol 2007;7:1003-12. (Pubitemid 46891320)
30. Lee J, Lee EN, Kim EY, Park HJ, Chang CY, Jung DY, et al. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease. Immunol Lett 2005;101:210-6. (Pubitemid 41368080)
31. García-Olmo D, García-Arranz M, García LG, Cuellar ES, Blanco IF, Prianes LA, et al. Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy. Int J Colorectal Dis 2003;18:451-4. (Pubitemid 37062740)